Oncolys BioPharma Inc.【JP:4588】Cash flow
Market cap
¥37.9B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 13 | 17 | 15 | 1 | 2 | 3 | 5 | 6 | 1 | 2 | 1 |
| Cash from operations | -814 | -756 | -903 | -1,097 | -1,188 | -238 | -1,465 | -1,742 | -1,717 | -1,337 | -2,020 |
| Capital expenditures | -23 | - | -21 | -1 | -2 | -3 | -3 | -1 | -1 | -6 | -4 |
| Cash from investing | -3,409 | 1,755 | 257 | 132 | 342 | -4 | -38 | -1 | 20 | -5 | -5 |
| Repurchases of common stock | - | - | - | - | - | - | -0 | -0 | -0 | - | - |
| Proceeds from issuance of term debt, net | 35 | - | - | 100 | - | 200 | 100 | 100 | 100 | 100 | 100 |
| Repayments of term debt | -30 | -33 | -33 | -25 | -33 | -78 | -100 | -122 | -111 | -194 | -94 |
| Cash from financing | -0 | -120 | 6 | 1,477 | 1,147 | 1,123 | 242 | 3,091 | -114 | 1,143 | 2,879 |